
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Structure-guided protein design enables germline-targeting immunization strategies to generate broadly neutralizing antibodies against MPER, a region of the HIV envelope glycoprotein that is
functionally important and highly conserved, but a challenging target for antibody responses. Access through your institution Buy or subscribe This is a preview of subscription content,
access via your institution ACCESS OPTIONS Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $29.99
/ 30 days cancel any time Learn more Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on
SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about
institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Burton, D. R. & Hangartner, L. _Annu. Rev. Immunol._ 34, 635–659 (2016). Article CAS PubMed PubMed
Central Google Scholar * Sneller, M. C. et al. _Nature_ 606, 375–381 (2022). Article CAS PubMed PubMed Central Google Scholar * Schiffner, T. et al. _Nat. Immunol._
https://doi.org/10.1038/s41590-024-01833-w (2024). Article PubMed Google Scholar * Ray, R. et al. _Nat. Immunol._ https://doi.org/10.1038/s41590-024-01844-7 (2024). Article PubMed
Google Scholar * Julien, J.-P. et al. _Science_ 342, 1477–1483 (2013). Article CAS PubMed Google Scholar * Haynes, B. F. et al. _Nat. Rev. Immunol._ 23, 142–158 (2023). Article CAS
PubMed Google Scholar * Huang, J. et al. _Nature_ 491, 406–412 (2012). Article CAS PubMed PubMed Central Google Scholar * Jardine, J. G. et al. _Science_ 351, 1458–1463 (2016).
Article CAS PubMed PubMed Central Google Scholar * Leggat, D. J. et al. _Science_ 378, eadd6502 (2022). Article CAS PubMed PubMed Central Google Scholar Download references AUTHOR
INFORMATION AUTHORS AND AFFILIATIONS * Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, USA Tobias V. Lanz * Division of Immunology and Rheumatology,
Department of Medicine, Stanford University, Stanford, CA, USA Tobias V. Lanz Authors * Tobias V. Lanz View author publications You can also search for this author inPubMed Google Scholar
CORRESPONDING AUTHOR Correspondence to Tobias V. Lanz. ETHICS DECLARATIONS COMPETING INTERESTS The author declares no competing interests. RIGHTS AND PERMISSIONS Reprints and permissions
ABOUT THIS ARTICLE CITE THIS ARTICLE Lanz, T.V. Germline-targeting immunogens guide bnAb development. _Nat Immunol_ 25, 944–946 (2024). https://doi.org/10.1038/s41590-024-01852-7 Download
citation * Published: 30 May 2024 * Issue Date: June 2024 * DOI: https://doi.org/10.1038/s41590-024-01852-7 SHARE THIS ARTICLE Anyone you share the following link with will be able to read
this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative